Kimberly-Clark to Acquire Kenvue
Kimberly-Clark has announced a cash and stock acquisition of Kenvue, the maker of Tylenol, valued at approximately $48.7 billion.
Merger Details
Upon completion, Kimberly-Clark shareholders will own about 54% of the combined company, while Kenvue shareholders will hold 46%.
Combined Brands
The merger brings together popular consumer brands, including Kenvue’s Tylenol, Listerine, and Band-Aid, alongside Kimberly-Clark’s Cottonelle, Huggies, and Kleenex.
“We will serve billions of consumers across every stage of life,” said Kimberly-Clark Chairman and CEO Mike Hsu.
Leadership and Governance
Mike Hsu will lead as chairman and CEO of the merged company, and three Kenvue board members will join Kimberly-Clark’s board upon closing.
Author’s summary: Kimberly-Clark acquires Kenvue for $48.7 billion.